Skip to content

Sustainability of Pulmonary Rehab Gains

Sustainability of Rehabilitation Gains in COPD

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02241733
Enrollment
80
Registered
2014-09-16
Start date
2014-10-01
Completion date
2019-08-12
Last updated
2019-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Keywords

exercise, pulmonary rehabilitation, dynamic hyperinflation

Brief summary

People with moderate to severe COPD trap air in their lungs. This lessens their ability to exercise. The investigators developed a computerized breathing retraining program to help patients empty their lungs during exercise. The investigators believe that learning to control breathing will help patients be more active. The purpose of this study is to test the effects of using breathing retraining (intervention group) versus no breathing retraining (control group) as part of a 12-week exercise program. The investigators are examining the long term effects of this training on exercise capacity and the ability to empty ones lungs during exercise. Patients will participate in a 12-week exercise program, with or without breathing retraining. They will then participate in a 42 week adherence program to maintain physical activity. Patient testing will be competed at baseline, 12 weeks, 6 months and 1 year. 250 patients with moderate to severe COPD will be enrolled.

Detailed description

Rationale: Development of dynamic hyperinflation is a primary limiting factor of exercise tolerance in chronic obstructive pulmonary disease (COPD). To lessen the development of dynamic hyperinflation, and to improve exercise tolerance in COPD patients, the investigators have developed a breathing-retraining technique to be used during pulmonary rehabilitation. This breathing-retraining technique is designed to decrease respiratory rate and prolong exhalation. The investigators demonstrated that, in the short-term, hyperinflation and exercise duration improved more with breathing-retraining plus exercise-training than with exercise-training alone. Because a crucial aspect of pulmonary rehabilitation is the maintenance its short-term benefits over the long-term, the investigators now propose to test whether short-term benefits of breathing-retraining plus exercise followed by an adherence-intervention program are sustainable over the long-term Primary Hypothesis: (H1) In COPD patients, improvements in exercise duration on a constant- load treadmill test will be greater after 12 weeks of breathing-retraining plus exercise-training followed by a 42-week adherence-intervention program (1 yr. total) than after 12 weeks of exercise-training alone followed by a 42-week adherence-intervention program (1 yr. total). Secondary Hypotheses: One year after randomization, exercise-induced dynamic hyperinflation will be less during a constant-load treadmill test (H2), 6-minute walking distance will be longer (H3), and mastery over breathing will be greater (H4) in the breathing-retraining plus exercise-training group than in the exercise-alone group. Lastly (exploratory objective), the investigators will assess the effect of the patient's physiologic, psychologic and clinical phenotype on short- term and long-term responsiveness to pulmonary rehabilitation. Methods: The proposed study is a randomized, controlled clinical trial in which 250 patients with moderate-to-severe COPD will be enrolled. One hundred forty of these patients are expected to qualify for randomization into the breathing-retraining plus exercise-training group or the exercise-training alone group. Patients will receive 12-weeks of supervised training according to group assignment (three times weekly) followed by an adherence-intervention program (weekly phone motivational interviews, home-exercise program, and monthly laboratory booster sessions). Follow-up testing will be completed at 12 weeks, and at 6 and 12 months. Testing will include pulmonary function test, incremental-load and constant-load treadmill tests, 6-minute walk test, measurements of dyspnea, assessment of respiratory and quadriceps muscle strength and endurance and quadriceps ultrasonography. Analysis: In the principal analysis of the primary outcome measure (exercise duration; H1) the investigators will compare changes in exercise duration (constant work-rate treadmill test) from baseline to end of study using 2-sample t-test (two-tailed =.05). The primary analysis will be based on intention-to-treat principles. Multiple imputation will be used for study subjects missing the 12-month measurement. This imputation model will be based on baseline characteristics of study participants. Several secondary analyses of the primary outcome measure will be performed (H2-H4). Linear regression will be used to determine whether the observed treatment benefits persist after adjustment for baseline covariates and measures of adherence to treatment. Since several measurements will be taken on each patient, mixed-models analysis will be used to compare the changes on the constant-load treadmill test over time between the two groups.

Interventions

BEHAVIORALBreathing retraining plus exercise

Patients will participate in a 12-week exercise program with breathing retraining. They will also participate in an adherence program.

BEHAVIORALExercise only

Patients will participate in a 12-week exercise program . They will also participate in an adherence program.

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* \>/= 40 yrs * FEV1 \</= 70% predicted * FEV1/FVC \<70% predicted * RV/TLC \>/=120% * SpO2 \>/= 90% at peak exercise (with or without exercise) * inspiratory capacity decline \>.15L from rest to peak exercise

Exclusion criteria

* respiratory infection/exacerbation within the previous 4 weeks * exercise limiting heart disease * primary asthma * congestive heart failure * exercise limiting peripheral arterial disease * stops exercise due to arthritic pain in the knee or hips * inability to walk on the treadmill * pregnancy * methadone use * any unforeseen illness or disability that would preclude exercise testing or training * participation in a formal exercise program within the previous 12 weeks

Design outcomes

Primary

MeasureTime frameDescription
Duration of Exercise Time on a Constant Work-rate Treadmill Test52 week testPatients walk on a treadmill set at a constant workrate. The difference in the time walked on the treadmill from baseline to study completion is the primary outcome measure.

Secondary

MeasureTime frameDescription
Inspiratory Capacity52 week testInspiratory capacity is measured at a set time during the constant workrate treadmill test. The difference between the inspiratory capacity measured at baseline and 52 weeks is a secondary outcome. Inspiratory capacity measured during exercise is a measure of dynamic hyperinflation.
6 Minute Walk Distance52 weeksSix-minute walk distance will be measured at 52 weeks. The difference in distance walked in meters between baseline and 52 weeks is the secondary outcome measure. The 6 minute walk is conducted using the guidelines issued by the American Thoracic Society.
Mastery Over Breathing52 weeksMastery over breathing is measured using the Chronic Respiratory Disease Questionnaire. Specifically the subscale 'mastery is the investigators' secondary outcome. The difference in scores from baseline to 52 weeks is the investigators' outcome measure. The Chronic Respiratory Disease Questionnaire is a valid and reliable questionnaire. 1=minimum score, 7=maximum with the higher score indicating greater mastery. A higher score indicates better health. A change of 0.5 indicates a small change, 1.0 indicates a moderate change and greater or equal to a change of 1.5 indicates a large change.

Countries

United States

Participant flow

Participants by arm

ArmCount
Exercise
Patients will exercise for 12 weeks and then participate in an adherence program Exercise only: Patients will participate in a 12-week exercise program . They will also participate in an adherence program.
40
Exercise Plus Breathing Retraining
Patients will exercise plus breathing retraining for 12 weeks and then participate in an adherence program Breathing retraining plus exercise: Patients will participate in a 12-week exercise program with breathing retraining. They will also participate in an adherence program.
40
Total80

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyDeath02
Overall StudyLost to Follow-up94
Overall StudyPhysician Decision62
Overall StudyWithdrawal by Subject02

Baseline characteristics

CharacteristicExerciseTotalExercise Plus Breathing Retraining
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
28 Participants54 Participants26 Participants
Age, Categorical
Between 18 and 65 years
12 Participants26 Participants14 Participants
Age, Continuous66.5 years
STANDARD_DEVIATION 6.6
67.4 years
STANDARD_DEVIATION 6.6
68.3 years
STANDARD_DEVIATION 6.6
Ethnicity (NIH/OMB)
Hispanic or Latino
4 Participants5 Participants1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
36 Participants75 Participants39 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Inspiratory capacity2.09 liters
STANDARD_DEVIATION 0.69
1.99 liters
STANDARD_DEVIATION 0.59
1.88 liters
STANDARD_DEVIATION 0.49
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
11 Participants19 Participants8 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
29 Participants61 Participants32 Participants
Region of Enrollment
United States
40 Participants80 Participants40 Participants
Sex: Female, Male
Female
2 Participants3 Participants1 Participants
Sex: Female, Male
Male
38 Participants77 Participants39 Participants
Time walked on constant workload treadmill test7.2 minutes walked
STANDARD_DEVIATION 1.9
7.2 minutes walked
STANDARD_DEVIATION 1.9
7.1 minutes walked
STANDARD_DEVIATION 2

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
1 / 402 / 40
other
Total, other adverse events
0 / 400 / 40
serious
Total, serious adverse events
16 / 4015 / 40

Outcome results

Primary

Duration of Exercise Time on a Constant Work-rate Treadmill Test

Patients walk on a treadmill set at a constant workrate. The difference in the time walked on the treadmill from baseline to study completion is the primary outcome measure.

Time frame: 52 week test

Population: A multiple imputation model was used to impute missing values for those who did not complete the 52 weeks of the program.

ArmMeasureValue (MEAN)Dispersion
ExerciseDuration of Exercise Time on a Constant Work-rate Treadmill Test12.2 change in number of minutes walkedStandard Deviation 3.5
Exercise Plus Breathing RetrainingDuration of Exercise Time on a Constant Work-rate Treadmill Test12.5 change in number of minutes walkedStandard Deviation 3.5
Comparison: An independent t-test was completed.p-value: 0.94t-test, 2 sided
Secondary

6 Minute Walk Distance

Six-minute walk distance will be measured at 52 weeks. The difference in distance walked in meters between baseline and 52 weeks is the secondary outcome measure. The 6 minute walk is conducted using the guidelines issued by the American Thoracic Society.

Time frame: 52 weeks

Population: Multiple imputation procedures were used to impute data for those that did not complete the protocol

ArmMeasureValue (MEAN)Dispersion
Exercise6 Minute Walk Distance25.9 metersStandard Deviation 8.5
Exercise Plus Breathing Retraining6 Minute Walk Distance22.8 metersStandard Deviation 8.7
p-value: 0.8t-test, 2 sided
Secondary

Inspiratory Capacity

Inspiratory capacity is measured at a set time during the constant workrate treadmill test. The difference between the inspiratory capacity measured at baseline and 52 weeks is a secondary outcome. Inspiratory capacity measured during exercise is a measure of dynamic hyperinflation.

Time frame: 52 week test

Population: A multiple imputation model was used to impute values for those who did not complete the program. The score below is the difference between 52 weeks and baseline.

ArmMeasureValue (MEAN)Dispersion
ExerciseInspiratory Capacity-0.02 difference in liters inspiredStandard Deviation 0.07
Exercise Plus Breathing RetrainingInspiratory Capacity.15 difference in liters inspiredStandard Deviation 0.07
p-value: 0.078t-test, 2 sided
Secondary

Mastery Over Breathing

Mastery over breathing is measured using the Chronic Respiratory Disease Questionnaire. Specifically the subscale 'mastery is the investigators' secondary outcome. The difference in scores from baseline to 52 weeks is the investigators' outcome measure. The Chronic Respiratory Disease Questionnaire is a valid and reliable questionnaire. 1=minimum score, 7=maximum with the higher score indicating greater mastery. A higher score indicates better health. A change of 0.5 indicates a small change, 1.0 indicates a moderate change and greater or equal to a change of 1.5 indicates a large change.

Time frame: 52 weeks

Population: Multiple imputation was used to impute missing values for those who did not complete the protocol.

ArmMeasureValue (MEAN)Dispersion
ExerciseMastery Over Breathing1.9 score on a scaleStandard Deviation 4.9
Exercise Plus Breathing RetrainingMastery Over Breathing2.3 score on a scaleStandard Deviation 4.6
p-value: 0.76t-test, 2 sided

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026